Apple Watch
Apple Watch

Apple appeals ban on Watch Series 9 and Ultra 2

What To Know

  • Apple has filed an appeal with the International Trade Commission (ITC) to overturn the ban on US sales of the Apple Watch Series 9 and Ultra 2, court records reveal.
  • The origin of this situation dates back to the ITC ruling, which found the company in violation of a blood oxygen saturation tracking technology patent owned by health tech firm Masimo.
  • As a result, Apple is working on new sensors for the affected smartwatch models, while the Watch SE remains unaffected as it lacks a blood oxygen sensor.
  • For consumers seeking the Watch Series 9 and Ultra 2, these smartwatches are still available for purchase in other parts of the world, as the ban only applies to the US.

Apple has filed an appeal with the International Trade Commission (ITC) to overturn the ban on US sales of the Apple Watch Series 9 and Ultra 2, court records reveal. Simultaneously, the company is seeking an emergency stay on the ban until a decision is made regarding proposed redesigns for both smartwatch models.

In a statement to Reuters, Apple mentioned that it is “taking all measures to return” the affected smartwatches to US store shelves, with the appeal being a crucial part of this effort.

Despite seeking intervention from President Biden, who did not veto the decision, the ban officially takes effect today. Apple began removing the smartwatches from its digital and physical storefronts last week.

In its filing today, Apple asserts that it will “suffer irreparable harm” if the ban persists. The Exclusion Order Enforcement Branch of U.S. Customs and Border Protection is set to decide on Apple’s redesigned versions of the smartwatches on January 13.

Apple takes a stance and appeals the ban on Watch Series 9 and Ultra 2

The origin of this situation dates back to the ITC ruling, which found the company in violation of a blood oxygen saturation tracking technology patent owned by health tech firm Masimo. Apple attempted a software fix, but both the ITC and Masimo agreed that a hardware redesign was necessary.

As a result, Apple is working on new sensors for the affected smartwatch models, while the Watch SE remains unaffected as it lacks a blood oxygen sensor.

Masimo sued Apple in 2021 over alleged patent violations and the poaching of employees with expertise in blood oxygen monitoring capabilities. There is a possibility that the two companies may reach a financial settlement to resolve the issue.

For consumers seeking the Watch Series 9 and Ultra 2, these smartwatches are still available for purchase in other parts of the world, as the ban only applies to the US. Alternatively, third-party retailers in the US may have stock until it runs out, but direct purchases from Apple are currently restricted.

The Watch constitutes approximately half of the entire smartwatch market, underscoring the significance of the ban’s potential impact on Apple’s business.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *